Interchangeability and Pharmacy Substitution Worldwide

References: 1. Health Canada. Fact Sheet: Biosimilars. www.canada.ca/en/health-canada/services/drugs-health-products/ biologics-radiopharmaceuticals-genetic-therapies/applications-submissions/guidance-documents/fact-sheet-biosimilars.html. Accessed February 25, 2019. 2. US Food and Drug Administration. Draft Guidance for Industry: Scientific Considerations in Demonstrating Interchangeability With a Reference Product. www.fda.gov/downloads/drugs/guidance/compliance/regulatory/information/guidances/ucm537135.pdf. Accessed December 21, 2018. 3. National Conference of State Legislatures. State Laws and Legislation Related to Biologic Medications and Substitution of Biosimilars. www.ncsl.org/research/health/state-laws-and-legislation-related-to-biologic-medications-and-substitution-of-biosimilars.aspx. Accessed December 21, 2018. 4. Generics and Biosimilars Initiative. Biosimilar Substitution in Europe. www.gabionline.net/Reports/Biosimilar-substitution-in-Europe. Accessed February 25, 2019. 5. Generics and Biosimilars Initiative. Interchangeability of biosimilars around the world. www.gabionline.net/Reports/lnterchangeability-of-biosimilars-around-the-world. Accessed February 25, 2019.